These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
360 related articles for article (PubMed ID: 7761479)
1. Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity. Bhol K; Natarajan K; Nagarwalla N; Mohimen A; Aoki V; Ahmed AR Proc Natl Acad Sci U S A; 1995 May; 92(11):5239-43. PubMed ID: 7761479 [TBL] [Abstract][Full Text] [Related]
2. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Bhol K; Mohimen A; Ahmed AR Dermatology; 1994; 189 Suppl 1():85-9. PubMed ID: 8049571 [TBL] [Abstract][Full Text] [Related]
3. Pathogenicity and Epitope Characteristics Do Not Differ in IgG Subclass-Switched Anti-Desmoglein 3 IgG1 and IgG4 Autoantibodies in Pemphigus Vulgaris. Lo AS; Mao X; Mukherjee EM; Ellebrecht CT; Yu X; Posner MR; Payne AS; Cavacini LA PLoS One; 2016; 11(6):e0156800. PubMed ID: 27304671 [TBL] [Abstract][Full Text] [Related]
4. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Kricheli D; David M; Frusic-Zlotkin M; Goldsmith D; Rabinov M; Sulkes J; Milner Y Br J Dermatol; 2000 Aug; 143(2):337-42. PubMed ID: 10951142 [TBL] [Abstract][Full Text] [Related]
5. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Hacker MK; Janson M; Fairley JA; Lin MS Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995 [TBL] [Abstract][Full Text] [Related]
6. Circulating pemphigus autoantibodies in healthy relatives of pemphigus patients: coincidental phenomenon with a risk of disease development? Torzecka JD; Woźniak K; Kowalewski C; Waszczykowska E; Sysa-Jedrzejowska A; Pas HH; Narbutt J Arch Dermatol Res; 2007 Aug; 299(5-6):239-43. PubMed ID: 17534636 [TBL] [Abstract][Full Text] [Related]
7. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells. Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957 [TBL] [Abstract][Full Text] [Related]
8. Enrichment of total serum IgG4 in patients with pemphigus. Funakoshi T; Lunardon L; Ellebrecht CT; Nagler AR; O'Leary CE; Payne AS Br J Dermatol; 2012 Dec; 167(6):1245-53. PubMed ID: 22803659 [TBL] [Abstract][Full Text] [Related]
9. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221 [TBL] [Abstract][Full Text] [Related]
10. Induction of blister-causing antibodies by a recombinant full-length, but not the extracellular, domain of the pemphigus vulgaris antigen (desmoglein 3). Memar O; Christensen B; Rajaraman S; Goldblum R; Tyring SK; Brysk MM; McCormick DJ; el-Zaim H; Fan JL; Prabhakar BS J Immunol; 1996 Oct; 157(7):3171-7. PubMed ID: 8816430 [TBL] [Abstract][Full Text] [Related]
11. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039 [TBL] [Abstract][Full Text] [Related]
12. Pemphigus immunoglobulin G subclass autoantibodies: studies of reactivity with cultured human keratinocytes. Kim YH; Geoghegan WD; Jordon RE J Lab Clin Med; 1990 Mar; 115(3):324-31. PubMed ID: 2179435 [TBL] [Abstract][Full Text] [Related]
13. Subclass characteristics of IgG autoantibodies in bullous pemphigoid and pemphigus. Shirakata Y; Shiraishi S; Sayama K; Miki Y J Dermatol; 1990 Nov; 17(11):661-6. PubMed ID: 2094743 [TBL] [Abstract][Full Text] [Related]
14. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Wucherpfennig KW; Yu B; Bhol K; Monos DS; Argyris E; Karr RW; Ahmed AR; Strominger JL Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11935-9. PubMed ID: 8524878 [TBL] [Abstract][Full Text] [Related]
15. Pemphigus: a Comprehensive Review on Pathogenesis, Clinical Presentation and Novel Therapeutic Approaches. Pollmann R; Schmidt T; Eming R; Hertl M Clin Rev Allergy Immunol; 2018 Feb; 54(1):1-25. PubMed ID: 29313220 [TBL] [Abstract][Full Text] [Related]
16. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides. Dworschak J; Recke A; Freitag M; Ludwig RJ; Langenhan J; Kreuzer OJ; Zillikens D; Schmidt E J Dermatol Sci; 2012 Feb; 65(2):102-9. PubMed ID: 22261006 [TBL] [Abstract][Full Text] [Related]
17. Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris. Tong JC; Tan TW; Sinha AA; Ranganathan S BMC Bioinformatics; 2006 Dec; 7 Suppl 5(Suppl 5):S7. PubMed ID: 17254312 [TBL] [Abstract][Full Text] [Related]
18. Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus. Futei Y; Amagai M; Hashimoto T; Nishikawa T J Am Acad Dermatol; 2003 Dec; 49(6):1023-8. PubMed ID: 14639380 [TBL] [Abstract][Full Text] [Related]
19. Investigations on the nature and pathogenicity of circulating antikeratinocyte antibodies in dogs with pemphigus foliaceus. Olivry T; Dunston SM; Walker RH; Alhaidari Z; Messinger L; Liu Z Vet Dermatol; 2009 Feb; 20(1):42-50. PubMed ID: 19152586 [TBL] [Abstract][Full Text] [Related]
20. Affinity immunoblotting studies on the restriction of autoantibodies from endemic pemphigus foliaceus patients. Calvanico NJ; Swartz SJ; Diaz LA J Autoimmun; 1993 Apr; 6(2):145-57. PubMed ID: 8499057 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]